97 related articles for article (PubMed ID: 9923553)
1. Effects of amifostine on perfused isolated rat heart and on acute doxorubicin-induced cardiotoxicity.
Nazeyrollas P; Prévost A; Baccard N; Manot L; Devillier P; Millart H
Cancer Chemother Pharmacol; 1999; 43(3):227-32. PubMed ID: 9923553
[TBL] [Abstract][Full Text] [Related]
2. Efficiency of amifostine as a protection against doxorubicin toxicity in rats during a 12-day treatment.
Nazeyrollas P; Frances C; Prevost A; Costa B; Lorenzato M; Kantelip JP; Elaerts J; Millart H
Anticancer Res; 2003; 23(1A):405-9. PubMed ID: 12680240
[TBL] [Abstract][Full Text] [Related]
3. A short-time model to study relevant indices of cardiotoxicity of doxorubicin in the rat.
Hole LD; Larsen TH; Fossan KO; Limé F; Schjøtt J
Toxicol Mech Methods; 2013 Jul; 23(6):412-8. PubMed ID: 23379389
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats.
Herman EH; Zhang J; Chadwick DP; Ferrans VJ
Cancer Chemother Pharmacol; 2000; 45(4):329-34. PubMed ID: 10755322
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of selenium, WR-2721, and their combination in the prevention of adriamycin-induced cardiotoxicity in rats.
Dobrić S; Dragojević-Simić V; Bokonjić D; Milovanović S; Marincić D; Jović P
J Environ Pathol Toxicol Oncol; 1998; 17(3-4):291-9. PubMed ID: 9726805
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of anthracycline cardiotoxicity with the model of isolated, perfused rat heart: comparison of new analogues versus doxorubicin.
Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J
Cancer Chemother Pharmacol; 1995; 35(3):257-61. PubMed ID: 7805186
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of mitochondrial membrane potential prevents doxorubicin-induced cardiotoxicity in isolated rat heart.
Montaigne D; Marechal X; Baccouch R; Modine T; Preau S; Zannis K; Marchetti P; Lancel S; Neviere R
Toxicol Appl Pharmacol; 2010 May; 244(3):300-7. PubMed ID: 20096298
[TBL] [Abstract][Full Text] [Related]
8. Effects of three new anthracyclines and doxorubicin on the rat isolated heart.
Chen ZM; Colombo T; Conforti L; Grazia Donelli M; Fiedorowicz RJ; Marchi S; Paolini A; Riva E; Zuanetti G; Latini R
J Pharm Pharmacol; 1987 Nov; 39(11):947-50. PubMed ID: 2892924
[TBL] [Abstract][Full Text] [Related]
9. Amifostine protects against early but not late toxic effects of doxorubicin in infant rats.
Jahnukainen K; Jahnukainen T; Salmi TT; Svechnikov K; Eksborg S; Söder O
Cancer Res; 2001 Sep; 61(17):6423-7. PubMed ID: 11522636
[TBL] [Abstract][Full Text] [Related]
10. FGF-2 and FGF-16 protect isolated perfused mouse hearts from acute doxorubicin-induced contractile dysfunction.
Sontag DP; Wang J; Kardami E; Cattini PA
Cardiovasc Toxicol; 2013 Sep; 13(3):244-53. PubMed ID: 23430353
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of gallium chloride on ventricular function and metabolism of the Langendorff perfused rat heart.
Millart H; Leperre A; Kantelip JP; Collery P; Descous I; Trenque T; Lamiable D
Anticancer Res; 1993; 13(6A):2251-6. PubMed ID: 8297141
[TBL] [Abstract][Full Text] [Related]
12. The effects of isosteviol against myocardium injury induced by ischaemia-reperfusion in the isolated guinea pig heart.
Xu D; Zhang S; Foster DJ; Wang J
Clin Exp Pharmacol Physiol; 2007; 34(5-6):488-93. PubMed ID: 17439420
[TBL] [Abstract][Full Text] [Related]
13. Effects of dexrazoxane and amifostine on evolution of Doxorubicin cardiomyopathy in vivo.
Bjelogrlic SK; Radic J; Radulovic S; Jokanovic M; Jovic V
Exp Biol Med (Maywood); 2007 Dec; 232(11):1414-24. PubMed ID: 18040065
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotection of rat heart myocytes with amifostine (Ethyol) and its free thiol, WR-1065, in vitro.
Dorr RT; Lagel K; McLean S
Eur J Cancer; 1996; 32A Suppl 4():S21-5. PubMed ID: 8976818
[TBL] [Abstract][Full Text] [Related]
15. Acute doxorubicin cardiotoxicity: functional, metabolic, and morphologic alterations in the isolated, perfused rat heart.
Pelikan PC; Weisfeldt ML; Jacobus WE; Miceli MV; Bulkley BH; Gerstenblith G
J Cardiovasc Pharmacol; 1986; 8(5):1058-66. PubMed ID: 2429080
[TBL] [Abstract][Full Text] [Related]
16. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of doxorubicin cardiotoxicity by carnitine is specific of the L-diasteroisomer.
Maccari F; Ramacci MT
Biomedicine; 1981 May; 35(2):65-7. PubMed ID: 7260239
[TBL] [Abstract][Full Text] [Related]
18. Acute exercise protects against doxorubicin cardiotoxicity.
Wonders KY; Hydock DS; Schneider CM; Hayward R
Integr Cancer Ther; 2008 Sep; 7(3):147-54. PubMed ID: 18815146
[TBL] [Abstract][Full Text] [Related]
19. Investigation of doxorubicin tissue toxicity: does amifostine provide chemoprotection? An experimental study.
Rigatos SK; Stathopoulos GP; Dontas I; Perrea-Kotsarelis D; Couris E; Karayannacos PE; Deliconstantinos G
Anticancer Res; 2002; 22(1A):129-34. PubMed ID: 12017274
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of paracetamol in doxorubicin-induced cardiotoxicity in ischemia/reperfused isolated rat heart.
Hesari M; Shackebaei D; Asadmobini A
Anatol J Cardiol; 2018 Feb; 19(2):94-99. PubMed ID: 29350208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
